RCT | Intravenous immune globulin reduces disease activity in dermatomyositis.
6 Oct, 2022 | 13:48h | UTCTrial of Intravenous Immune Globulin in Dermatomyositis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
NEJM: trial of IVIG for autoimmune disorder dermatomyositis – MedicalResearch.com
IV Immune Globulin Bests Placebo for Dermatomyositis – Drugs.com